News

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results

PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage…

1 year ago

BioVie to Present Overview of Bezisterim Clinical Data on Longevity at 11th Aging Research and Drug Discovery Meeting

Presentation to showcase potential impact of bezisterim on biological age, gene expression and measures of aging-related diseases from growing body…

1 year ago

Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development

Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX:…

1 year ago

Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board

New Advisory Board Member Will Initially Focus On Venowave Sales & Business DevelopmentToronto, Ontario--(Newsfile Corp. - August 13, 2024) -…

1 year ago

FendX Announces Publication of Results of Its Pathogen Detection Nanotechnology

AI-enhanced nanotechnology demonstrated highly reliable pathogen detectionOakville, Ontario--(Newsfile Corp. - August 13, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

1 year ago

Sinch AI Used to Safely Pre-Triage Patients

STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Sinch  (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world…

1 year ago

SPECTUM DYNAMICS MEDICAL AND DEEPDENSE MEDICAL ENTER INTO A PARTNERSHIP TO REVOLUTIONIZE AI IN CARDIAC AND SPINE DISEASE IMAGING AND TREATMENT

SARASOTA, Fla., Aug. 13, 2024 /PRNewswire/ -- Spectrum Dynamics Medical, a leading innovator in digital SPECT-CT imaging solutions, announced that…

1 year ago

Cantargia Presents the Interim Report for Q2 2024 on August 28 at 3.00 p.m.

LUND, SE / ACCESSWIRE / August 13, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) will publish the company's…

1 year ago

Defence Therapeutics Collaboration Agreement with Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer Advances

Vancouver, British Columbia--(Newsfile Corp. - August 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

1 year ago

New Scientific Article on NeuroRestore ACD856 and its Improved Cognition and Disease Modification of Alzheimer’s Disease

STOCKHOLM, SE / ACCESSWIRE / August 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

1 year ago